Can someone with better medical knowledge elucidate for me why MSB's Covid19 treatment trial does not view with the same lens as that of Gilead's Remdesivir treatment trial. TIA
Countdown to Interim Analysis, page-59
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
-0.035(3.48%) |
Mkt cap ! $1.096B | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.01 | 94.0¢ | $5.042M | 5.212M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 83814 | 96.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.0¢ | 20921 | 6 |
View Market Depth
| Last trade - 11.21am 31/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |